SCHEMBL23275693

SCHEMBL23275693

Cn1cc(Nc2nccc(-c3ccc(CNCC(F)(F)F)cc3)n2)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MKNK1 Q9BUB5 1/20 0.53
▸ JAK2 O60674 3/20 0.52
▸ JAK1 P23458 2/20 0.52
▸ TYK2 P29597 2/20 0.52
▸ JAK3 P52333 2/20 0.52
▸ STAT3 P40763 1/20 0.52
▸ BTK Q06187 15/20 0.51
▸ MAPK3 P27361 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ MAP3K14 Q99558 1/20 0.45
▸ CD69 Q07108 2/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ HRH2 P25021 1/20 0.44
▸ CDK7 P50613 1/20 0.44
▸ AAK1 Q2M2I8 1/20 0.44
▸ MAP3K19 Q56UN5 1/20 0.44
▸ CDKL2 Q92772 1/20 0.44
▸ RIOK1 Q9BRS2 1/20 0.44
▸ RIOK2 Q9BVS4 1/20 0.44
▸ BMP2K Q9NSY1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23275720 0.84 JAK2 (0.64) MKNK1JAK2JAK1TYK2JAK3
SCHEMBL23275852 0.81 JAK2 (0.56) JAK2JAK1TYK2JAK3STAT3
SCHEMBL27228673 0.79 JAK2 (0.55) JAK2JAK1TYK2JAK3STAT3
SCHEMBL23281857 0.78 JAK3 (0.56) JAK2JAK1TYK2JAK3STAT3
SCHEMBL23275741 0.78 JAK2 (0.59) JAK2JAK1TYK2JAK3STAT3
SCHEMBL23275848 0.77 JAK2 (0.56) JAK2JAK1TYK2JAK3STAT3
SCHEMBL23275644 0.77 JAK2 (0.67) JAK2JAK1TYK2JAK3STAT3
SCHEMBL23312113 0.77 JAK1 (0.56) MKNK1JAK2JAK1TYK2JAK3
SCHEMBL23281910 0.76 JAK1 (0.58) JAK2JAK1TYK2JAK3STAT3
SCHEMBL19557885 0.75 BTK (0.56) JAK2JAK1TYK2JAK3STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174648-A1 Small Molecule Compound TECHNODERMA MEDICINES INC. (CN) 2024-05-30 — — US disclosed
EP-4050009-A1 SMALL MOLECULE COMPOUND Technoderma Medicines Pte Ltd (CN) 2022-08-31 — — EP disclosed
WO-2021078023-A1 SMALL MOLECULE COMPOUND 嘉兴特科罗生物科技有限公司 2021-04-29 — — WO disclosed
WO-2021078023-A1 SMALL MOLECULE COMPOUND 嘉兴特科罗生物科技有限公司 2021-04-29 — — WO disclosed
CN-110627775-A Small molecule compound 嘉兴特科罗生物科技有限公司 2019-12-31 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174648-A1 Small Molecule Compound JAK1, JAK2, TYK2 MKNK1 237/4885JAK2 2/4885JAK1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback